HEART DISEASE/ CARDIOVASCULAR

 

Effects of cannabis roots on the heart.                    (abst – 1973)

http://jama.jamanetwork.com/article.aspx?articleid=349755

 

Intravenous delta9-Tetrahydrocannabinol: Effects of ventilatory control and cardiovascular dynamics.   (full – 1975)  http://journals.lww.com/anesthesiology/pages/articleviewer.aspx?year=1975&issue=06000&article=00008

&type=abstract

 

The Effects of Delta-9-Tetrahydrocannabinol (Cannabis) on Cardiac Performance with and without Beta Blockade                                                                 (full – 1976)  http://circ.ahajournals.org/cgi/reprint/53/4/703?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=mar   ihuana&searchid=1&FIRSTINDEX=2080&resourcetype=HWCIT

 

Short-term effects of smoked marihuana on left ventricular function in man

(full – 1977)                        http://journal.publications.chestnet.org/data/Journals/CHEST/20995/20.pdf

 

 

 

 

 

 

 

 

 

A cannabinoid with cardiovascular activity but no overt behavioral effects.   (abst – 1977)

http://www.ncbi.nlm.nih.gov/pubmed/891878

 

Propranolol Effects on Acute Marihuana Intoxication in Man.              (abst – 1977)

http://www.ncbi.nlm.nih.gov/pubmed/403557

 

The effect of cannabichromene on mean blood pressure, heart rate, and respiration rate responses to tetrahydrocannabinol in the anesthetized rat                                       (abst – 1979)  http://www.sciencedirect.com/science/article/pii/0041008X79902503

 

Cannabinoids. II. Cardiovascular Effects              (full – 1980)  http://jpet.aspetjournals.org/content/214/1/131.full.pdf+html?ijkey=e751d405c4b7e494c235b602119e4f9b  8c62c04d&keytype2=tf_ipsecsha

 

The cardiovascular and autonomic effects of repeated administration of delta-9- tetrahydrocannabinol to rhesus monkeys.                                                                  (abst – 1981)  http://www.ncbi.nlm.nih.gov/pubmed/6257883

 

Effects of acute marijuana smoking in post-menopausal women.             (abst – 1986)

http://www.ncbi.nlm.nih.gov/pubmed/3094054

 

The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation.                                                         (abst – 1989)  http://www.ncbi.nlm.nih.gov/pubmed/2575149

 

Changes in middle cerebral artery velocity after marijuana                (abst – 1992)

http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1420630&dopt=Abstract

 

Development of HU-211 as a neuroprotectant for ischemic brain damage.             (abst – 1995)

http://www.ncbi.nlm.nih.gov/pubmed/7477742

 

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.      (abst – 1995)                         http://www.ncbi.nlm.nih.gov/pubmed/7589169

 

Cannabinoid-Induced Hypotension and Bradycardia in Rats Is Mediated by CB1-Like Cannabinoid Receptors  (full – 1997)  http://jpet.aspetjournals.org/content/281/3/1030.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext

=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT

 

Cardiovascular effects of endocannabinoids–the plot thickens.             (abst – 2000)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=10785543&dopt=abstrac  tplus

 

Involvement of central and peripheral cannabinoid receptors in the regulation of heart resistance to arrhythmogenic effects of epinephrine.                                                               (abst – 2000)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11182823&dopt=abstrac tplus

 

 

 

 

 

 

 

 

Endogenous cannabinoids mediate hypotension after experimental myocardial infarction (full – 2001)  http://content.onlinejacc.org/cgi/content/full/38/7/2048?maxtoshow=&hits=80&RESULTFORMAT=&fullt  ext=cannabinoid&searchid=1&FIRSTINDEX=560&resourcetype=HWCIT

 

Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries (full – 2001)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573021/?tool=pmcentrez

 

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts                                                        (full – 2001)  http://cardiovascres.oxfordjournals.org/content/55/3/619.full?sid=750cba66-d3d1-484d-96e8-  04975ba34325

 

Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors.                                                                (abst – 2001)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11427912&dopt=abstrac tplus

 

Influence of the CB1 receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats                                                       (full – 2002)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573379/?tool=pmcentrez

 

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts.                                                        (full – 2002)  http://cardiovascres.oxfordjournals.org/content/55/3/619.long

 

Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation        (full – 2002)  http://bloodjournal.hematologylibrary.org/content/100/12/4040.full

 

Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis. (abst – 2002)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=12428278&dopt=abstrac  tplus

 

Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors                                                                     (abst – 2002)  http://www.ncbi.nlm.nih.gov/pubmed/12227101

 

Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors                                                         (abst – 2002)  http://www.ncbi.nlm.nih.gov/pubmed/12136723

 

Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism.                                                       (abst – 2002)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=12428277&dopt=abstrac tplus

 

Endocannabinoids protect the rat isolated heart against ischaemia               (full – 2003)

 

 

 

 

 

 

 

 

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573907/?tool=pmcentrez

 

Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery (full – 2003)                                 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573773/?tool=pmcentrez

 

CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction (full – 2003)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573770/?tool=pmcentrez

 

Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN                                                    (full – 2003)  http://www.jleukbio.org/cgi/content/full/75/3/453?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=  cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT

 

A new endothelial target for cannabinoids.              (full – 2003)

http://molpharm.aspetjournals.org/content/63/3/469.long

 

Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?                                          (full – 2003)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573769/?tool=pmcentrez

 

Cannabinoids prevented the development of heart failure in animal study            (news – 2003)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=145#2

 

Cardiovascular Effects of Cannabis             (news – 2003)     http://www.idmu.co.uk/canncardio.htm

 

Marijuana Smoking Doesn’t Kill                (news – 2003)

http://www.webmd.com/smoking-cessation/news/20030918/marijuana-smoking-doesnt-kill

 

Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension          (full – 2004)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756479/?tool=pmcentrez

 

The complexities of the cardiovascular actions of cannabinoids               (full – 2004)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574918/?tool=pmcentrez

 

Characterisation of the vasorelaxant properties of the novel endocannabinoid N- arachidonoyl-dopamine (NADA).                                                                          (full – 2004)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574254/

 

Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.                                           (abst – 2004)       http://www.ncbi.nlm.nih.gov/pubmed/15233865

 

Cardiovascular Pharmacology of Cannabinoids               (full – 2005)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228270/?tool=pmcentrez

 

Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia–reperfusion by a novel cannabinoid mechanism                                                      (full – 2005)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751211/?tool=pmcentrez

 

 

 

 

 

 

 

 

 

Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats                                                              (full – 2005)  http://bja.oxfordjournals.org/content/94/5/563.full

 

The cardiovascular actions of anandamide: more targets?               (full – 2005)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576182/?tool=pmcentrez

 

Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors                                                         (full – 2005)  http://gut.bmj.com/content/54/4/522.full?sid=0731f0e5-2071-4549-be57-57f444307138

 

Cardiac and vascular effects of cannabinoids: toward a therapeutic use?             (abst – 2005)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=15828464&dopt=abstrac tplus

 

CARDIOVASCULAR Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats (abst – 2005)                                  http://academic.research.microsoft.com/Paper/11905213

 

Influence of Anandamide, the Endogenous Agonist of Cannabinoid Receptors on the Circulatory System                                             (abst – 2005)          http://www.ncbi.nlm.nih.gov/pubmed/15928605

 

MEDICAL BIOLOGY: MARIJUANA AND THE HEART             (news – 2005)

http://scienceweek.com/2005/sw050617-5.htm

 

Marijuana Chemical Fights Hardened Arteries               (news – 2005)

http://www.webmd.com/heart-disease/news/20050406/marijuana-chemical-fights-hardened-arteries

 

Medical marijuana: study shows that THC slows atherosclerosis               (news – 2005)

http://thenexthurrah.typepad.com/the_next_hurrah/2005/04/medical_marijua.html

 

Cannabis chemical ‘helps heart’             (news – 2005)    http://news.bbc.co.uk/2/hi/health/4417261.stm

 

Further Characterization of the Time-Dependent Vascular Effects of Δ9- Tetrahydrocannabinol  (full – 2006)                                                   http://jpet.aspetjournals.org/content/317/1/428.full

 

Illicit Drug Use in Young Adults and Subsequent Decline in General Health: The Coronary Artery Risk Development in Young Adults (CARDIA) Study                                                (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885466/?tool=pmcentrez

 

Signaling pathways involved in the cardioprotective effects of cannabinoids. (full – 2006)                                  https://www.jstage.jst.go.jp/article/jphs/102/2/102_2_155/_pdf

 

Does Cannabis Hold the Key to Treating Cardiometabolic Disease              (full – 2006)

http://www.nature.com/nrcardio/journal/v3/n3/full/ncpcardio0504.html

 

 

 

 

 

 

 

 

The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia. (abst – 2006)                                       http://www.ncbi.nlm.nih.gov/pubmed/16618028

 

Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production                                                           (abst – 2006)  http://www.ingentaconnect.com/content/klu/mcbi/2006/00000283/F0020001/00002346

 

Marijuana use, diet, body mass index, and cardiovascular risk factors               (abst – 2006)

http://www.ncbi.nlm.nih.gov/pubmed/16893701

 

Cannabis use not associated with risk factors for diseases of heart and circulation (news – 2006)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=225#2

 

THC protects heart cells in the case of lowered oxygen supply                (news – 2006)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=212#1

 

Cannabinoid Offers Cardioprotection              (news – 2006)

http://www.norml.org/index.cfm?Group_ID=6818&wtm_format=print

 

Heavy Cannabis Use Not Independently Associated With Cardiovascular Risks (news – 2006)                                     http://www.norml.org/index.cfm?Group_ID=6972

 

The in vitro and in vivo cardiovascular effects of {Delta}9-tetrahydrocannabinol (THC) in rats made hypertensive by chronic inhibition of nitric oxide synthase. (full – 2007)  http://jpet.aspetjournals.org/content/321/2/663.full

 

Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta           (full – 2007)                http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190007/?tool=pubmed

 

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.                                                   (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190033/?tool=pubmed

 

Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats   (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225474/?tool=pmcentrez

 

Endocannabinoids and the haematological system              (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190025/?tool=pmcentrez

 

Cannabinoids and cardiovascular disease: a tale of passions and illusions. (full – 2007)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013961/?tool=pubmed

 

Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.                                                              (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225473/?tool=pubmed

 

 

 

 

 

 

 

 

GPR55 and the vascular receptors for cannabinoids.               (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190021/?tool=pubmed

 

Cannabidiol , a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.  (full – 2007)  http://ajpheart.physiology.org/cgi/content/full/293/6/H3602

 

Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats (full – 2007)                                  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190006/?tool=pmcentrez

 

Effect of dietary hempseed intake on cardiac ischemia-reperfusion injury.            (full – 2007)

http://ajpregu.physiology.org/content/292/3/R1198.long

 

Cannabinoids and cardiovascular disease: the outlook for clinical treatments. (abst – 2007)

http://www.ncbi.nlm.nih.gov/pubmed/17627561?ordinalpos=1&itool=PPMCLayout.PPMCAppController.   PPMCArticlePage.PPMCPubmedRA&linkpos=5

 

Cannabinoids as therapeutic agents in cardiovascular disease               (abst – 2007)  http://www.unboundmedicine.com/medline/ebm/record/17450170/abstract/Cannabinoids_as_therapeutic_a gents_in_cardiovascular_disease:_a_tale_of_passions_and_illusions

 

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9- tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/

 

Cannabinoid receptors in acute and chronic complications of atherosclerosis (full – 2008)                                   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219535/?tool=pmcentrez

 

Endocannabinoids and Liver Disease. V. Endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis                                                        (full – 2008)  http://ajpgi.physiology.org/content/295/4/G649.full?sid=c16d770d-cd17-48c9-bbde-26f38f5eeb67

 

CB1 Cannabinoid Receptor Inhibition: Promising Approach for Heart Failure? (full – 2008)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669829/?tool=pmcentrez

 

‘Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.                                                                         (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597234/?tool=pubmed

 

Modulation of the Endocannabinoid System in Cardiovascular Disease

(full – 2008)              http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568884/?tool=pmcentrez

 

Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats    (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697765/?tool=pmcentrez

 

Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning          (full – 2008)

 

 

 

 

 

 

 

 

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219536/?tool=pmcentrez

 

Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product.                                                  (full – 2008)  http://www.ncbi.nlm.nih.gov/pubmed/18806815

 

Endocannabinoids, blood pressure and the human heart.              (full – 2008).

http://www3.interscience.wiley.com/cgi-bin/fulltext/119409853/HTMLSTART

 

The endocannabinoid system: an osteopathic perspective.                (full – 2008)

http://www.jaoa.org/cgi/content/full/108/10/586

 

Function of cannabinoids in heart failure                (link to full – 2008)  http://www.unboundmedicine.com/medline/citation/18464680/abstract/%5BFunction_of_cannabinoids_in_ heart_failure%5D

 

Dexanabinol prevents development of vasospasm in the rat femoral artery model. (abst – 2008)                                     http://www.ncbi.nlm.nih.gov/pubmed/18256864

 

Endocannabinoids and cardiac contractile function: pathophysiological implications. (full – 2009)                                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768548/?tool=pubmed

 

Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner                                                  (full – 2009)  http://cardiovascres.oxfordjournals.org/content/85/1/56.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb

 

Endocannabinoids and the Heart             (full – 2009)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728560/?tool=pmcentrez

 

The emerging role of the endocannabinoid system in cardiovascular disease (full – 2009)                                 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791499/?tool=pmcentrez

 

Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work?   (full – 2009)  http://cardiovascres.oxfordjournals.org/content/84/3/341.full?sid=7d2438c4-a727-410f-870d-  4a971695b4fb

 

CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages                                                (full – 2009)  http://cardiovascres.oxfordjournals.org/content/84/3/378.full?sid=7d2438c4-a727-410f-870d-  4a971695b4fb

 

Time-dependent vascular actions of cannabidiol in the rat aorta.             (abst – 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19285060

 

Cannabidiol Attenuates Myocardial Dysfunction, Fibrosis, Inflammation, Cell Death and Interrelated Signaling Pathways Associated With Diabetic Cardiomyopathy

(abst – 2009)

 

 

 

 

 

 

 

 

http://circ.ahajournals.org/cgi/content/meeting_abstract/120/18_MeetingAbstracts/S868?maxtoshow=&hits

=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=1680&resourcetype=HWC  IT

 

Endocannabinoids and cardiovascular prevention: real progress?                (abst – 2009)

http://www.pagepress.org/journals/index.php/hi/article/view/1162

 

CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion           (abst – 2009)                                         http://www.ncbi.nlm.nih.gov/pubmed/19162037

 

Cannabinoids and atherosclerosis.                (abst – 2009)  http://www.ncbi.nlm.nih.gov/pubmed/19591373?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPa   nel.Pubmed_RVDocSum&ordinalpos=13

 

Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.                                                                   (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/?tool=pubmed

 

Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.                                                                   (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003779/

 

The cardiac and haemostatic effects of dietary hempseed.              (full – 2010)

http://www.nutritionandmetabolism.com/content/pdf/1743-7075-7-32.pdf

 

Endogenous cannabinoid signaling is essential for stress adaptation               (full – 2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889099/?tool=pmcentrez

 

US Patent Application 20100158973 – THERAPEUTIC USES OF CANNABIDIOL

COMPOUNDS            (full – 2010)    http://www.patentstorm.us/applications/20100158973/fulltext.html

 

Pharmacologically induced hypothermia with cannabinoid receptor agonist WIN55, 212- 2 after cardiopulmonary resuscitation                                                          (abst – 2010)  http://journals.lww.com/ccmjournal/Abstract/2010/12000/Pharmacologically_induced_hypothermia_with.2

.aspx

 

Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion. (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20590615

 

Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/19931541

 

Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery                                                                             (abst – 2010)  http://www.unboundmedicine.com/medline/ebm/record/20718749/abstract/Interaction_between_anandami   de_and_sphingosine_1_phosphate_in_mediating_vasorelaxation_in_rat_coronary_artery_

 

 

 

 

 

 

 

 

Lab Notes: Pot Has Benefits for Diabetic Hearts              (news – 2010)

http://www.medpagetoday.com/LabNotes/LabNotes/23853

 

Inhaled Incense “K2” May Cause Heart Damage               (news – 2010)

http://drwes.blogspot.com/2010/08/inhaled-incense-k2-may-cause-heart.html

 

Suicides in other trials led to early termination of trial into effects of weight loss drug rimonabant on cardiovascular outcomes (CRESCENDO study)                                                                 (news – 2010)  http://www.eurekalert.org/pub_releases/2010-08/l-sio081110.php

 

Cannabidiol (CBD) as an Anti-Arrhythmic – the Role of the CB1 Receptors (news – 2010)

http://cannabisclinicians.org/2011/cannabidiol-cbd-as-an-anti-arrhythmic-the-role-of-the-cb1-receptors/

 

Pot Compound Mitigates Diabetic Cardiomyopathy              (news – 2010)

http://www.norml.org/index.cfm?Group_ID=8424

 

The potential for clinical use of cannabinoids in treatment of cardiovascular diseases. (full – 2011)                                     http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5922.2010.00233.x/pdf

 

Endocannabinoid system in cardiovascular disorders – new pharmacotherapeutic opportunities    (full – 2011)

http://www.jpbsonline.org/article.asp?issn=0975-  7406;year=2011;volume=3;issue=3;spage=350;epage=360;aulast=Cunha

 

Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion                                                                 (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/?tool=pubmed

 

Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/

 

Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors.             (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/22116907/abstract/17_Cannabidiol_as_an_anti_arr hythmic_the_role_of_the_CB1_receptors_

 

Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease.                                                     (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21294251

 

Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice.                                                       (abst – 2011)    http://www.ncbi.nlm.nih.gov/pubmed/21785110

 

G1359A polymorphism in the cannabinoid receptor-1 gene is associated with coronary artery disease in the Chinese Han population.                                                                 (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/22029183

 

The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia.                                                                 (abst – 2011)

 

 

 

 

 

 

 

 

http://www.ncbi.nlm.nih.gov/pubmed/21331775

 

Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression.                                                         (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21309057/abstract/Win_55212_2_reduces_cardiac

_ischaemia_reperfusion_injury_in_zucker_diabetic_fatty_rats:_role_of_cb2_receptors_and_cardiac_inos/e nos_expression_

 

Cannabinoid-2 Receptor Activation Protects against Infarct and Ischemia/Reperfusion Heart Injury.      (abst – 2011)                         http://www.ncbi.nlm.nih.gov/pubmed/22113346

 

Effect of substance abuse on defibrillation threshold in patients with implantable cardioverter-defibrillator.                                                     (abst – 2011)     http://www.ncbi.nlm.nih.gov/pubmed/20946279

 

Endocannabinoids and the cardiovascular response to stress.              (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21708837

 

Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.         (abst – 2011)                                    http://www.ncbi.nlm.nih.gov/pubmed/21802885

 

Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress.                                                              (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21771609

 

Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease.                                                           (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21633404

 

The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits.                                               (abst – 2011)    http://www.ncbi.nlm.nih.gov/pubmed/21893466

 

Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury.                                               (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21470162/abstract/Targeting_the_Endocannabinod

_System_to_Limit_Myocardial_and_Cerebral_Ischemic_and_Reperfusion_Injury_

 

Cannabidiol (CBD) as an Anti-Arrhythmic                 (abst – 2011)

http://cannabisclinicians.org/2011/cannabidiol-cbd-as-an-anti-arrhythmic-the-role-of-the-cb1-receptors/

 

Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women.  (abst – 2011)          http://www.ncbi.nlm.nih.gov/pubmed/21480765

 

Marijuana Compounds Hold Promise In Treatment Of Cardiovascular Diseases (news – 2011)                                           http://www.norml.org/index.cfm?Group_ID=8466

 

Hemp Fiber Cereal            (news – 2011)    http://www.livestrong.com/article/524253-hemp-fiber-cereal/

 

 

 

 

 

 

 

 

Cannabinoids and atherosclerotic coronary heart disease.              (full – 2012)

http://onlinelibrary.wiley.com/doi/10.1002/clc.21962/pdf

 

Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.                                                                 (full – 2012)  http://www.jbc.org/content/early/2012/07/11/jbc.M112.346296.full.pdf+html

 

Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids.                                                      (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372498/

 

Targeting cannabinoid receptor CB(2 ) in cardiovascular disorders: promises and controversies.   (full – 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/full

 

Phytoestrogens Enhance the Vascular Actions of the Endocannabinoid Anandamide in Mesenteric Beds of Female Rats                                                          (full – 2012)  http://www.hindawi.com/journals/ijht/2012/647856/

 

Cannabinoid 1 (CB1) receptor mediates WIN55, 212-2 induced hypothermia and improved survival in a rat post-cardiac arrest model.                                                                  (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22289684

 

G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary artery disease in patients with type 2 diabetes.                                                                        (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22138970

 

Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation.                                                       (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22285599

 

Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.                                             (abst – 2012)        http://www.ncbi.nlm.nih.gov/pubmed/22260337

 

Cannabinoid receptor CB2 protects against balloon-induced neointima formation. (abst – 2012)                                    http://www.ncbi.nlm.nih.gov/pubmed/22227125

 

Vascular metabolism of anandamide to arachidonic acid affects myogenic constriction in response to intraluminal pressure elevation.                                                       (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22285599

 

The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users.           (abst – 2012)                         http://www.ncbi.nlm.nih.gov/pubmed/22921474

 

Anandamide enhances expression of heat shock protein 72 to protect against ischemia- reperfusion injury in rat heart.                                                    (abst – 2012)     http://www.ncbi.nlm.nih.gov/pubmed/23007622

 

 

 

 

 

 

 

 

Tolerance to Effects of High-Dose Oral {Delta}9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers.                                                                         (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23074216

 

Cannabis misinterpretation and misadventure in a coroner’s court.                    (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/23155125

 

Essential fatty acids and lipid mediators. Endocannabinoids                       (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22730630

 

Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology.                                                (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23253273

 

Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice                                                                 (abst – 2012)  http://eurheartj.oxfordjournals.org/content/33/24/3124.short?rss=1

 

Tachycardia followed by bradycardia after smoking the synthetic cannabinoid “K9″ (news – 2012)                                         http://www.thepoisonreview.com/2012/05/22/tachycardia-followed-by-bradycardia-  after-smoking-the-synthetic-cannabinoid-k9/

 

Surinabant, a selective CB(1) antagonist, inhibits THC-induced central nervous system and heart rate effects in humans.                                                             (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23278647

 

Is the cardiovascular system a therapeutic target for cannabidiol?                     (abst – 2013)

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04351.x/abstract

 

Pot Smoking Not Linked To Greater Risk Of Death For Those With Coronary Disease (news – 2013)

http://norml.org/news/2013/01/31/study-marijuana-smoking-not-associated-with-greater-mortality-risk- among-heart-attack-survivors

 

Share a link for